Clinical Trial: Multi-Center Clinical Trial of Shenling Baizhu Granules for Preventing Low-Risk Colorectal Adenoma Recurrence

U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06930157) titled 'Multi-Center Clinical Trial of Shenling Baizhu Granules for Preventing Low-Risk Colorectal Adenoma Recurrence' on April 08.

Brief Summary: The goal of this clinical trial is to learn if Shenling Baizhu granules can prevent colorectal adenoma from coming back in people who had low-risk colorectal adenomas removed. The main questions it aims to answer are:

* Can Shenling Baizhu granules lower the rate of colorectal adenoma returning after removal?

* How safe is Shenling Baizhu granules when used long-term for preventing adenoma?

* Which patients are most likely to benefit from this treatment?

Researchers will compare Shenling Bai...